Gilead Sciences Inc., GILD is in the exchange NASDAQ and its industry is Biotechnology in the sector of Healthcare. Based in USA, Gilead Sciences Inc., GILD has a market cap of 97242.74. Since its IPO date on the 1/22/1992, Gilead Sciences Inc., GILD performance year to date is -26.91%. Today Gilead Sciences Inc., GILD has gained -0.42%, with a current price of 72.75.
Ownership of the company is 0.40% for insider ownership while institutional ownership is 80.50%. The management of the company have seen the company have a payout ratio of 15.20%. Return of assets are at 32.70%, with return on investment at 45.90%.
In terms of debt levels and profit levels, Gilead Sciences Inc., GILD is seeing a long-term debt/equity of 1.38. While Total debt/equity is 1.42. With a profit margin of 50.50%, this is combined with a gross margin of 87.10%, and operating margin of 63.00%. Gilead Sciences Inc. ability to meet debt levels, with a current ratio of 1.8, while the quick ratio is 1.6.
For the last year Gilead Sciences Inc., GILD has seen a EPS growth of 62.00%. A performance for the year of -26.92%. The 52-week high is -33.15%, and the 52-week low is 0.75%. The average volume for Gilead Sciences Inc., GILD is 7344032.
With a target price of 102.89, can Gilead Sciences Inc., GILD reach this target? Looking at the value indicators of Gilead Sciences Inc., GILD. Gilead Sciences Inc. has a P/E of 6.41 and a forward P/E of 6.31. Perhaps the more useful indicator than P/E, is PEG which has a value of *TBA. Gilead Sciences Inc. also has a P/S and a P/B of 3 and 6.25 respectively. For P/cash, Gilead Sciences Inc. has a value of 11.11, while it is 6.69 for P/free cash flow.
At the current price of 72.75, Gilead Sciences Inc. has a dividend yield of 2.58%. We see a return on equity of 100.80%.
Looking more long-term Gilead Sciences Inc., is projected to get an EPS growth for the next five years of -0.27%. In the short-term an EPS growth of -2.24% in the next year is forecasted. This is after a EPS growth of 62.00% for this year and for the last five years a 48.30% growth has been seen.